2005
DOI: 10.1073/pnas.0504054102
|View full text |Cite
|
Sign up to set email alerts
|

Up-regulation of β-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells

Abstract: The protein levels of ␤-catenin are tightly regulated by the ubiquitin͞proteasome system. We provide evidence that two distinct ubiquitin-dependent degradation pathways for ␤-catenin are active in the same Burkitt's lymphoma cells: Along with the classical glycogen-synthase kinase 3␤-dependent destruction machinery, degradation of ␤-catenin through seven in absentia homolog 1 (Siah-1) ubiquitin ligase is functional in these cells. We show that inhibition of endogenous Siah-1 stabilizes and activates ␤-catenin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
49
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(52 citation statements)
references
References 36 publications
3
49
0
Order By: Relevance
“…Importantly, this mechanism is GSK-3b-independent and, indeed (like NS5A), LMP1 and LiCl exhibited an additive effect on b-catenin transcriptional activity. Furthermore, LMP1 was able to activate a mutant b-catenin that was unable to be phosphorylated by GSK-3b (S37A) (Jang et al, 2005). It will be intriguing to determine whether NS5A also modulates the Siah-1 pathway of b-catenin regulation; current efforts in our laboratory are investigating this topic.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Importantly, this mechanism is GSK-3b-independent and, indeed (like NS5A), LMP1 and LiCl exhibited an additive effect on b-catenin transcriptional activity. Furthermore, LMP1 was able to activate a mutant b-catenin that was unable to be phosphorylated by GSK-3b (S37A) (Jang et al, 2005). It will be intriguing to determine whether NS5A also modulates the Siah-1 pathway of b-catenin regulation; current efforts in our laboratory are investigating this topic.…”
Section: Discussionmentioning
confidence: 99%
“…However, a more compelling explanation is suggested by the parallels between NS5A and the EBV latent membrane protein 1 (LMP1), which also activates b-catenin (Shackelford et al, 2003). LMP1 has been shown to inhibit an alternative pathway of b-catenin ubiquitination, involving the Siah-1 (seven in absentia homologue 1) ubiquitin ligase (Jang et al, 2005). Importantly, this mechanism is GSK-3b-independent and, indeed (like NS5A), LMP1 and LiCl exhibited an additive effect on b-catenin transcriptional activity.…”
Section: Discussionmentioning
confidence: 99%
“…TBL1 Inhibits Siah-1-mediated ␤-Catenin Degradation in Cells-It has previously been shown that expression of Siah-1 correlates with reduced levels of ␤-catenin in cells (7)(8)(9)28). Overexpression of Siah-1 in the absence of a Wnt ligand reduced levels of ␤-catenin and lowered the induction of Tcf/ Lef target genes (7,8).…”
Section: ␤-Catenin Ubiquitination By Siah-1 Protection By Tbl1mentioning
confidence: 99%
“…p53 directly induces the expression of Siah-1 and in turn formation of a unique SCF-like complex (SCF(TBL1)) comprised of Siah-1, Siah-1-interacting protein (SIP), Skp1, transducin ␤-like 1 (TBL1), and APC (7,8). The physiological significance of Siah-1-targeted degradation of ␤-catenin is underscored by the discovery that this pathway is directly targeted by the viral oncoprotein latent membrane protein 1 (LMP1) (9). In addition, recent studies identified two drugs, hexachlorophene and isoreserpine, which attenuate the function of ␤-catenin through activation of Siah-1 and subsequent proteasomal degradation (10,11).…”
mentioning
confidence: 99%
“…Recently, ␤-catenin, which is a ligand-dependent coactivator of AR, has been shown to interact with HIF-1␣ (20,21). ␤-Catenin is much more highly expressed in prostate cancer, compared with normal prostate tissue (4,23). In the present study, we investigated whether HIF-1␣ and ␤-catenin coordinately enhance the transcriptional activity of AR at a low DHT level in prostate cancer cells.…”
mentioning
confidence: 99%